Recognition and prevention of cardiovascular disease in women

Area of Science:

• Cardiology
• Women's Health
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in women, exceeding cancer deaths.
• Unlike men, women have shown stagnant or increasing CVD mortality trends since 1979.
• A significant factor is the underestimation of CVD risk among women and healthcare providers.

Purpose of the Study:

• To highlight the critical need for assessing cardiovascular disease risk in women.
• To emphasize the importance of primary prevention strategies tailored to women.
• To clarify recommendations regarding menopausal hormone therapy for CVD prevention.

Main Methods:

• Analysis of cardiovascular mortality trends in men and women from 1979-2001.
• Review of current awareness levels regarding women's CVD risk.
• Evaluation of primary prevention strategies and hormone therapy guidelines.

Main Results:

• Cardiovascular mortality has decreased in men but remained steady or increased in women.
• Lack of awareness contributes to the disparity in CVD outcomes.
• Menopausal hormone therapy is not advised for preventing heart disease or stroke in women.

Conclusions:

• Routine cardiovascular disease risk assessment is essential for all women.
• Proactive primary prevention through lifestyle and medical interventions is recommended.
• Menopausal hormone therapy should not be used for primary prevention of coronary heart disease or stroke.